Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,265,544
-$51,307,258 QoQ
Shares Held
1,393,944
-44.8% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Deep Track Capital, LP holds $4,185,471,777 across 55 Biotechnology names. VRDN ranks #40 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
11,526,971 | $286,329,959 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,600,000 | $252,540,000 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,873,000 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
4,279,848 | $206,288,673 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
1,100,000 | $185,922,000 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,532,374 | $182,337,406 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $166,742,808 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
4,106,067 | $165,187,075 |
All Filings in VRDN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-05-01 | $72,704,997 | 5,417,660 | Shares | Sole | 2026-05-08 | |
| 2026-03-31 | $27,265,544 | 1,393,944 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,572,802 | 2,524,833 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $116,110,089 | 5,380,449 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,218,677 | 5,380,449 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $72,528,452 | 5,380,449 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $86,700,944 | 4,522,741 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $85,333,998 | 3,750,945 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $51,049,275 | 3,923,849 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $60,515,488 | 3,456,053 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $79,099,035 | 3,631,728 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,456,515 | 2,963,267 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,439,352 | 1,279,502 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $31,297,788 | 1,230,259 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $51,735,408 | 1,771,154 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $40,410,647 | 1,970,290 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,540,255 | 1,170,290 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $21,638,662 | 1,170,290 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $26,426,361 | 1,336,690 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||